REQUEST A DEMO
Total
USD $0.00
Search more companies

Acromax Laboratorio Quimico Farmaceutico S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Acromax Laboratorio Quimico Farmaceutico S.A. Profile Updated: January 11, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Spanish Download a sample report

Acromax Laboratorio Quimico Farmaceutico S.A. is a company based in Ecuador, with its head office in Guayaquil. It operates in the Pharmaceutical and Medicine Manufacturing sector. Acromax Laboratorio Quimico Farmaceutico S.A. was incorporated on October 18, 1963. Acromax Laboratorio Quimico Farmaceutico S.A. currently employs 407 (2019) people. From the latest financial highlights, Acromax Laboratorio Quimico Farmaceutico S.A. reported a net sales revenue drop of 12.08% in 2020. During that time, Acromax Laboratorio Quimico Farmaceutico S.A.’s total assets decreased by 0.74%. In, 2020, the company’s net profit margin decreased by 1.26%.

Headquarters
Km 8 1/2 Via Daule
Guayaquil; Guayas;

Contact Details: Purchase the Acromax Laboratorio Quimico Farmaceutico S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Acromax Laboratorio Quimico Farmaceutico S.A. report to view the information.
Outstanding Shares:
Purchase the Acromax Laboratorio Quimico Farmaceutico S.A. report to view the information.
Registered Capital:
Purchase the Acromax Laboratorio Quimico Farmaceutico S.A. report to view the information.
Ratings:
Purchase the Acromax Laboratorio Quimico Farmaceutico S.A. report to view the information.
Incorporation Date:
October 18, 1963
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.74%
Purchase this report to view the information.
0.26%
Subsidiaries
Company Performance
Financial values in the chart are available after Acromax Laboratorio Quimico Farmaceutico S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-12.08%
Total operating revenue
-15.4%
Operating profit (EBIT)
17.67%
EBITDA
10.1%
Net Profit (Loss) for the Period
-55.68%
Total assets
-0.74%
Total equity
2.17%
Operating Profit Margin (ROS)
1.36%
Net Profit Margin
-1.26%
Return on Equity (ROE)
-1.74%
Quick Ratio
0.17%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?